NR1H4 and metabolic syndrome: Thirdly, dysbiosis disrupts bile acid homeostasis and Farnesoid X receptor activation, impairing metabolic regulation and promoting dyslipidemia and chronic inflammation—key hallmarks of MetS progression to diabetes (8, 64).